CD133-positive cells purified from endometrial adenocarcinomas displayed a higher level of proteins associated with tumor progression (e.g., matrix metalloproteases, interleukin-8, CD44, and CXCR4) [23]. This evidence concerns the gene CD44 and neoplasm.